Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
House Report Blames Strict FDA for Drug Scarcity
Overly stringent enforcement by health regulators has caused the majority of drug shortages in the United States, according to a new report from a Republican-led House of Representatives committee.
The House Committee on Oversight and Government Reform said U.S. Food and Drug Administration inspections have forced four top generic drugmakers to shut down 30 percent of their manufacturing capacity, throwing the nation's drug supply into disarray.
Responding to the report, the FDA said preventing drug shortages is a "top priority," and that it works with companies to address serious quality issues and minimize supply disruptions.
Source: Reuters
Related Videos
Related Content
